Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. (Q54398301)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. |
scientific article |
Statements
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. (English)
Giuseppe Viale
Valentina Rossi
Franco Nolè
Stefania Redana
Laura Adamoli
Rossella Martinello
Gaetano Aurilio
Elena Verri
Filippo Montemurro
7 November 2013
23
1
44-49